课题基金 / 基金详情

项目摘要

项目成果

Michael Jackson的其他基金

相似基金

相关文献

中文摘要
翻译
第五单元.管理 第5股为伯纳姆中心提供领导,并确保与其他组成部分的协调, MLPCN。约翰·里德博士领导第5股,克里斯蒂娜·沃里博士担任联合主任。这支领导团队高度 在MLSCN阶段取得成功,并具有令人印象深刻的管理技能,包括在以下方面的直接经验: 开展大型合作研究项目。中心的日常工作流程由项目协调 经理,托马斯钟医生。Shakeela Dad博士是该中心的全职外联协调员。
英文摘要
UNIT 5. ADMINISTRATION Unit 5 provides leadership for the Burnham Center, and ensures coordination with other components of MLPCN. Dr. John Reed heads Unit 5, with Dr. Kristiina Vuori as co-Director. This leadership team was highly successful in the MLSCN Phase, and has impressive administrative skills, including direct experience in operating large collaborative research projects. Daily work-flow of the Center is coordinated by the Project Manager, Dr. Thomas Chung. Dr. Shakeela Dad functions as a full-time Outreach Coordinator for the Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
  • 批准号:
    10677899
  • 项目类别:
  • 资助金额:
    $77.22万
  • 财政年份:
    2023
  • 负责人:
    Michael Jackson
  • 依托单位:
Brain-penetrant GPR88 agonists as novel therapeutics for opioid abuse
Preventing Tau uptake by novel inhibitors of tau binding to LRP1
Preventing Tau uptake by novel inhibitors of tau binding to LRP1
海外基金